Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic Dermatitis
Clinical trial NCT04091646 · COMPLETED
Trial details
- NCT number
- NCT04091646
- Sponsor
- Arcutis Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-04
- Primary completion
- 2020-08-18
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.